Virta is the first clinically proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic diseases without the use of medications or surgery. Our innovations in nutritional biochemistry, data science, and digital tools combined with our clinical expertise are shifting the diabetes treatment paradigm from management to reversal. Our mission—to reverse type 2 diabetes in 100 million people by 2025.
Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, with sustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California.
Total Funding: $373 M
Funding Stage: Series E
Business Stage: Scaling Up
Market: B2C
Company Size: 251 to 500
Founded: 2014
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Virta Health
Senior Machine Learning Engineer, Applied AI
Remote, Remote
Machine Learning Engineer, Applied AI
Remote, Remote
Vice President, Customer Success
San Francisco, California
Vice President, Customer Success
Chicago, Illinois
Implementation Manager
Remote, Remote
